98%
921
2 minutes
20
Background: Sudden death (SD) due to ventricular tachycardia or fibrillation (VT/VF) detection failure in patients with implantable cardioverter-defibrillators (ICDs) has been reported, despite its rarity. However, the relationship between VF detection instability during defibrillation testing (DT) and SD risk is unknown.
Objective: To investigate whether VF sensing status during DT predicts SD and VT/VF detection failure in patients with ICD/cardiac resynchronization therapy with defibrillator (CRT-D).
Methods: Consecutive 97 patients with ICD/CRT-D (Medtronic) who underwent DT were identified retrospectively. "Induced VF with detection failure" was defined as an episode with at least four ventricular sensed beats out of the VF detection interval in the most recent 18 sensed beats during DT. Patients were divided into two groups (detection-failure or appropriate-detection group) according to the presence of "induced VF with detection failure". We investigated whether "induced VF with detection failure" predicts SD and inappropriate treatment interruption for clinically occurring VT/VF.
Results: Induced VF with detection failure was found in 8 of the 97 (8%) patients. During a median follow-up of 9.9 years (interquartile range: 7.2-11.8 years), 9 SD occurred. Univariate analysis showed induced VF with detection failure was the only predictor for SD (hazard ratio, 7.94, 95% confidence interval, 1.96 - 32.1, p = 0.004). During the follow-up, clinical VT/VF occurred in 41 patients. SD with inappropriate treatment interruption for a clinical VT/VF was observed in only three patients, two of them were in the detection-failure group [detection-failure: 2/5 (40%), appropriate-detection: 1/36 (3%)].
Conclusion: The instability of VF detection in DT may predict the uncertainty of detection during clinically occurring VT/VF that causes SD.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/jce.16790 | DOI Listing |
J Histotechnol
September 2025
Department of Pathology, Peking University Third Hospital, Beijing, China.
Amyloidosis encompasses a spectrum of rare disorders characterized by extracellular amyloid deposition. Achieving an accurate early diagnosis of systemic amyloidosis necessitates biopsy-specific pathological evaluation. Formalin-fixed, paraffin-embedded liver biopsy specimens were examined using Congo red staining, electron microscopy, immunohistochemistry (IHC), immunofluorescence, and Congo red-assisted laser microdissection with mass spectrometry (LMD/MS).
View Article and Find Full Text PDFEur J Case Rep Intern Med
August 2025
Department of Internal Medicine, Wayne State University School of Medicine, Trinity Health Oakland Hospital, Pontiac, USA.
Background: Invasive central nervous system (CNS) aspergillosis is rare among human immunodeficiency virus (HIV)-positive patients due to preserved neutrophil function, despite significant CD4+ T-cell depletion. Diagnosis typically requires histopathologic confirmation, but polymerase chain reaction (PCR) testing has introduced new challenges due to its high sensitivity but limited specificity.
Case Presentation: We describe a newly diagnosed 43-year-old HIV-positive male with concurrent Hodgkin lymphoma who presented with progressive neurological decline and a ring-enhancing brain lesion.
J Healthc Sci Humanit
January 2024
Assistant Professor & Clinical Coordinator, Health Informatics Program, School of Health Professions, State University of New York Downstate Health Sciences University, 450 Clarkson Avenue, MSC 94, Brooklyn, NY 11203, (718) 270-7738, Fax: (718) 270-7739 Email:
COVID-19 variants continue to infect thousands of people even though the end of the pandemic was announced on May 11, 2023. Nextstrain CoVariants (CoVariants) genomic databases provide detailed information about more than 31 variants of COVID-19 viruses that have been identified through genomic sequencing, showing the mutations they carry. Mutated viruses may yield a negative result for a gene target using a PCR test that has a positive COVID-19 test result.
View Article and Find Full Text PDFRev Cardiovasc Med
August 2025
Department of Cardiology, University Hospitals of Leicester NHS Trust, Glenfield Hospital, LE3 9QP Leicester, UK.
Adult congenital heart disease (ACHD) constitutes a heterogeneous and expanding patient cohort with distinctive diagnostic and management challenges. Conventional detection methods are ineffective at reflecting lesion heterogeneity and the variability in risk profiles. Artificial intelligence (AI), including machine learning (ML) and deep learning (DL) models, has revolutionized the potential for improving diagnosis, risk stratification, and personalized care across the ACHD spectrum.
View Article and Find Full Text PDFAnaesthesiologie
September 2025
Klinik für Anästhesiologie, Universitätsklinikum Düsseldorf, Heinrich-Heine-Universität, Moorenstr. 5, 40225, Düsseldorf, Deutschland.
Sodium-glucose Cotransporter 2 (SGLT-2) inhibitors are oral antidiabetic drugs that were developed for the treatment of patients with diabetes mellitus and are now also approved for treating chronic heart failure and chronic kidney disease. By inhibiting SGLT‑2 in the proximal renal tubule, urinary excretion of glucose is increased. Large randomized trials have demonstrated improved glycemic control, reduced cardiovascular events and lower mortality but also an increased risk of urogenital infections and dehydration.
View Article and Find Full Text PDF